Goode Paul — SEC Form 4 filings
SEC reporting owner CIK 1622251. 3 Form 4 filings on record with FilingPulse; latest filed 2025-10-07.
Transaction summary — filings shown
Covers all 3 filings on record, filed 2024-07-03 to 2025-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Glucotrack, Inc. (GCTK) | Chief Executive Officer, Director | 3 | — | — | 12 |
Form 4 filings — Goode Paul
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-07 | 4 | Glucotrack, Inc. (GCTK) | Other (J): 42 | EDGAR |
| 2025-03-28 | 4 | Glucotrack, Inc. (GCTK) | Conversion (C): 796 @ $31.20 · Other (J): 1,500 · Option exercise/expiry (X): 15,435 @ $0 · Grant/award (A): 3,277 (derivative) @ $0 · Purchase (P): 2,100 (derivative) · Purchase (P) @ $10,000 · +4 more | EDGAR |
| 2024-07-03 | 4 | GlucoTrack, Inc. (GCTK) | Purchase (P): 42,000 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1622251 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →